@inproceedings{inproceedings, title  = {{Cost-effectiveness of adalimumab (Humira (TM)) in the treatment of US patients with rheumatoid arthritis (RA)}},

 url = {{}},

 year = {{2004}},

 month = {{5}},

 author = {{Bansback N and Brennan A and Sengupta N}},

 volume = {{7}},

 journal = {{VALUE HEALTH}},

 issue = {{3}},

 pages = {{241-241}},

 note = {{Accessed on 2024/09/20}}}